Israel Englander’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-786,462
Closed -$14.5M 4286
2017
Q3
$14.5M Buy
786,462
+213,498
+37% +$3.7M 0.02% 979
2017
Q2
$9.49M Buy
572,964
+220,983
+63% +$3.07M 0.02% 1087
2017
Q1
$4.86M Buy
+351,981
New +$5.65M 0.01% 1469
2015
Q2
Sell
-35,324
Closed -$774K 4107
2015
Q1
$774K Buy
+35,324
New +$762K ﹤0.01% 2472

Other funds holding ENTL

Israel Englander's ENTL Position: Q4 2017 in Review

Israel Englander sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 786,462 shares — an estimated $14.5M sold.

Israel Englander first reported a position in ENTL in Q1 2015 and held it in 4 quarters. The position peaked at $14.5M in Q3 2017. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Israel Englander reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Israel Englander sold 786,462 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $14.5M.
  • Israel Englander first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 4 quarters.
  • Israel Englander's Entellus Medical, Inc. Common Stock position peaked at $14.5M in Q3 2017.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.